Data Availability
The data that support the findings of this study are openly available in Medicare Part B Physician Supplier Procedure Summary Master Files at https://data.cms.gov/summary-statistics-on-use-andpayments/physiciansupplier-procedure-summary.
References
Coldiron B, Ratnarathorn M (2014) Scope of physician procedures independently billed by mid-level providers in the office setting. JAMA Dermatol 150(11):1153–1159. https://doi.org/10.1001/jamadermatol.2014.1773
Gronbeck C, Feng H (2021) Volume and distribution of skin biopsies performed by dermatologists and other health care providers in the Medicare population in 2019. J Am Acad Dermatol. https://doi.org/10.1016/j.jaad.2021.11.006
Kircik LH (2019) A closer look at the new biopsy codes. Cutis 103(3):122–123
Patel S, Nguyen BT (2021) Characterization of biopsies by dermatologists and nonphysician providers in the Medicare population: a rapidly changing landscape. Dermatol Surg 47:1337–1341. https://doi.org/10.1097/dss.0000000000003150
US Centers for Medicare & Medicaid Services. Medicare provider utilization and payment data: physician and other supplier public use file. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/Physician-and-Other-Supplier.html. Accessed 8 Mar 2023.
Funding
Dr. Yeung is supported in part by the National Institute of Arthritis and Musculoskeletal and Skin Diseases under award number K23 AR075888 and L30 AR076081. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr. Duszak is a medical advisor and shareholder in Ethos Medical, Inc. During this study, he received related research funding from the Harvey L. Neiman Health Policy Institute.
Author information
Authors and Affiliations
Contributions
All authors made substantial contributions to conception and design, acquisition of data, and analysis and interpretation of data, been involved in drafting the manuscript, and revised it critically for important intellectual content and gave final approval of the version to be published. All authors agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Conflict of interest
None declared.
Ethical approval
Exempt.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, Y., Blalock, T., Duszak, R. et al. Use and cost of skin biopsy procedures in the Medicare Part B fee-for-service population, 2017 to 2020. Arch Dermatol Res 315, 2437–2439 (2023). https://doi.org/10.1007/s00403-023-02618-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-023-02618-1